Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
FDA Approves Ostial Pro Stent Positioning System
June 18th, 2007
The Food and Drug Administration has given approval for a Kalamazoo, MI-based company to begin marketing a one-of-a-kind device that allows physicians to more accurately place a stent in selected coronary and renal procedures. R. Kevin Plemmons, President and CEO of Ostial Solutions LLC, said his firm expects to begin marketing the Ostial Pro Stent Positioning System by mid-June "The Ostial Pro Stent Positioning System has very broad applications," said Plemmons, who received word of the FDA approval in late May. "We estimated that the device can be used in 90% to 95% of all renal aorta-ostial procedures and 7% of all coronary aorta-ostial...
Source: Health & Medicine Week (2007-06-18)
|
